JRP
FOLD

Jasper Ridge Partners’s Amicus Therapeutics FOLD Stock Holding History

Jasper Ridge Partners’s Portfolio FOLD Stock Details FOLD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q2 		– Sell
-14,441
Closed -$157K – 92
2015
Q1 		$157K Buy
+14,441
New +$127K 0.01% 87

Other funds holding FOLD

PA
Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.49B AUM 208.7% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
SAM
Sectoral Asset Management Montreal, Quebec, Canada $143M AUM 102.52% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return

Jasper Ridge Partners's FOLD Position: Q2 2015 in Review

Jasper Ridge Partners sold out of Amicus Therapeutics (FOLD) in Q2 2015, closing a stake of 14,441 shares — an estimated $157K sold.

Jasper Ridge Partners first reported a position in FOLD in Q1 2015 and held it in 1 quarter. The position peaked at $157K in Q1 2015. 140 funds tracked by Wall St. Rank hold FOLD as of Q2 2015.

  • Jasper Ridge Partners reported no remaining Amicus Therapeutics position as of Q2 2015 after selling out during the quarter.
  • Jasper Ridge Partners sold 14,441 Amicus Therapeutics shares in Q2 2015, an estimated $157K.
  • Jasper Ridge Partners first reported a position in Amicus Therapeutics in Q1 2015 and held it in 1 quarter.
  • Jasper Ridge Partners's Amicus Therapeutics position peaked at $157K in Q1 2015.
  • 140 funds tracked by Wall St. Rank held Amicus Therapeutics as of Q2 2015.

Based on Jasper Ridge Partners's 13F filing for Q2 2015, filed 13 Aug 2015.